• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

Introduction to 5-Chloro-6-phenylpyridin-3-amine (CAS No. 1780844-78-1)

5-Chloro-6-phenylpyridin-3-amine, identified by the Chemical Abstracts Service Number (CAS No.) 1780844-78-1, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic amine derivative has garnered attention due to its structural versatility and potential biological activities, making it a valuable scaffold for the development of novel therapeutic agents.

The molecular structure of 5-Chloro-6-phenylpyridin-3-amine consists of a pyridine ring substituted with a chlorine atom at the 5-position and a phenyl group at the 6-position, with an amine functional group at the 3-position. This arrangement imparts unique electronic and steric properties to the molecule, which can be exploited in drug design. The presence of both electron-withdrawing (chloro) and electron-donating (amine) groups enhances its reactivity, facilitating further chemical modifications and derivatization.

In recent years, there has been growing interest in exploring the pharmacological potential of 5-Chloro-6-phenylpyridin-3-amine and its derivatives. Research has indicated that this compound exhibits promising activities in several disease models, particularly in oncology and inflammatory disorders. The pyridine core is a common motif in many bioactive molecules, and modifications to this scaffold have led to the discovery of drugs with significant therapeutic value.

One of the most compelling aspects of 5-Chloro-6-phenylpyridin-3-amine is its ability to interact with biological targets such as kinases and transcription factors. These interactions are critical for modulating cellular signaling pathways that are dysregulated in various diseases. For instance, studies have shown that derivatives of this compound can inhibit the activity of specific kinases involved in cancer progression, suggesting their potential as anticancer agents. The chlorine substituent at the 5-position enhances binding affinity by participating in halogen bonding interactions with protein residues, further improving drug efficacy.

The phenyl group at the 6-position adds another layer of complexity to the molecule, influencing its solubility and metabolic stability. This feature is particularly important for drug development, as it can affect how the compound is absorbed, distributed, metabolized, and excreted (ADME) in vivo. By optimizing these structural elements, researchers can fine-tune the pharmacokinetic properties of 5-Chloro-6-phenylpyridin-3-amine derivatives to enhance their therapeutic index.

Recent advancements in computational chemistry have enabled more efficient screening of compounds like 5-Chloro-6-phenylpyridin-3-amine for biological activity. Machine learning models and molecular docking simulations have been employed to predict binding affinities and identify potential lead compounds for further development. These computational tools have accelerated the drug discovery process, allowing researchers to focus on the most promising candidates with greater precision.

In addition to its applications in oncology, 5-Chloro-6-phenylpyridin-3-amine has shown promise in treating inflammatory diseases. The amine group at the 3-position can engage with inflammatory mediators and signaling pathways, potentially reducing inflammation and alleviating symptoms associated with conditions such as rheumatoid arthritis and inflammatory bowel disease. Further research is needed to fully elucidate these mechanisms and translate these findings into clinical applications.

The synthesis of 5-Chloro-6-phenylpyridin-3-amine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic substitution reactions on halogenated pyridines followed by functional group transformations. Advances in synthetic methodologies have improved access to this compound, making it more readily available for research purposes.

The safety profile of 5-Chloro-6-phenylpyridin-3-am ine is an important consideration in its development as a therapeutic agent. Preliminary toxicology studies have indicated that this compound is well-tolerated at moderate doses, although further investigations are necessary to assess long-term effects. Understanding its toxicity profile is crucial for determining appropriate dosing regimens and minimizing potential side effects in clinical settings.

The future prospects for 5-Chloro -6 -phen ylpy ridin -3 -ami ne are exciting, with ongoing research exploring new derivatives and applications. Collaborative efforts between academia and industry are likely to drive innovation in this field, leading to novel treatments for a wide range of diseases. As our understanding of biological pathways continues to expand, compounds like 5-Chloro -6 -phen ylpy ridin -3 -ami ne will play an increasingly important role in modern medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)